Culturing of HIV-1-specific cytotoxic T lymphocytes with interleukin-7 and interleukin-15

Virology

Volumn 325, Issue 2, 2004, Pages 175-180

  Lubong, Rachel ^a   Ng, Hwee L ^a   Uittenbogaart, Christel H ^a,b   Yang, Otto O ^a,b,c  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytotoxic T lymphocyte; HIV 1; IL 15; IL 7

Indexed keywords

CHROMIUM; CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; PEPTIDE DERIVATIVE;

ARTICLE; CELL CLONE; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SERUM; TARGET CELL;

CELL CULTURE TECHNIQUES; CELL DIVISION; CELL SURVIVAL; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HIV-1; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-7; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 3142606913     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.04.036     Document Type: Article

References (43)

1. Agostini C., Trentin L., Sancetta R., Facco M., Tassinari C., Cerutti A., Bortolin M., Milani A., Siviero M., Zambello R., Semenzato G. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. Blood. 90(3):1997;1115-1123
2. Appay V., Rowland-Jones S.L. Premature ageing of the immune system: the cause of AIDS? Trends Immunol. 23(12):2002;580-585
3. Baalen C.A., Guillon C., Baalen Mv M., Verschuren E.J., Boers P.H., Osterhaus A.D., Gruters R.A. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur. J. Immunol. 32(9):2002;2644-2652
4. Brodie S.J., Lewinsohn D.A., Patterson B.K., Jiyamapa D., Krieger J., Corey L., Greenberg P.D., Riddell S.R. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5(1):1999;34-41
5. Brodie S.J., Patterson B.K., Lewinsohn D.A., Diem K., Spach D., Greenberg P.D., Riddell S.R., Corey L. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J. Clin. Invest. 105(10):2000;1407-1417
6. Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Ruckert R., Krause H., Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3(10):1997;1124-1128
7. Buseyne F., Fevrier M., Garcia S., Gougeon M.L., Riviere Y. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells. Virology. 225(1):1996;248-253
8. Chehimi J., Marshall J.D., Salvucci O., Frank I., Chehimi S., Kawecki S., Bacheller D., Rifat S., Chouaib S. IL-15 enhances immune functions during HIV infection. J. Immunol. 158(12):1997;5978-5987
9. Conlon P.J., Morrissey P.J., Nordan R.P., Grabstein K.H., Prickett K.S., Reed S.G., Goodwin R., Cosman D., Namen A.E. Murine thymocytes proliferate in direct response to interleukin-7. Blood. 74(4):1989;1368-1373
10. Fabbi M., Groh V., Strominger J.L. IL-7 induces proliferation of CD3-/low CD4-CD8-human thymocyte precursors by an IL-2 independent pathway. Int. Immunol. 4(1):1992;1-5
11. Ferrari G., King K., Rathbun K., Place C.A., Packard M.V., Bartlett J.A., Bolognesi D.P., Weinhold K.J. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clin. Exp. Immunol. 101(2):1995;239-248
12. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L.S., Cosman D., Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13(12):1994;2822-2830
13. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L.S., Anderson D.M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 14(15):1995;3654-3663
14. Gringhuis S.I., de Leij L.F., Verschuren E.W., Borger P., Vellenga E. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood. 90(7):1997;2690-2700
15. Gurney K.B., Yang O.O., Wilson S.B., Uittenbogaart C.H. TCR gamma delta+ and CD161+ thymocytes express HIV-1 in the SCID-hu mouse, potentially contributing to immune dysfunction in HIV infection. J. Immunol. 169(9):2002;5338-5346
16. Hickman C.J., Crim J.A., Mostowski H.S., Siegel J.P. Regulation of human cytotoxic T lymphocyte development by IL-7. J. Immunol. 145(8):1990;2415-2420
17. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., Irwin C.E., Safrit J.T., Mittler J., Weinberger L., Kostrikis L.G., Zhang L., Perelson A.S., Ho D.D. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189(6):1999;991-998
18. Kanai T., Thomas E.K., Yasutomi Y., Letvin N.L. IL-15 stimulates the expansion of AIDS virus-specific CTL. J. Immunol. 157(8):1996;3681-3687
19. Kim J.H., Loveland J.E., Sitz K.V., Ratto Kim S., McLinden R.J., Tencer K., Davis K., Burke D.S., Boswell R.N., Redfield R.R., Birx D.L. Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1. Clin. Exp. Immunol. 108(2):1997;243-250
20. Kim K., Lee C.K., Sayers T.J., Muegge K., Durum S.K. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J. Immunol. 160(12):1998;5735-5741
21. Koenig S., Conley A.J., Brewah Y.A., Jones G.M., Leath S., Boots L.J., Davey V., Pantaleo G., Demarest J.F., Carter C., et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1(4):1995;330-336
22. Lieberman J., Skolnik P.R., Parkerson G.R. III, Fabry J.A., Landry B., Bethel J., Kagan J. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood. 90(6):1997;2196-2206
23. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., Martin M.A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72(1):1998;164-169
24. McKinney D.M., Lewinsohn D.A., Riddell S.R., Greenberg P.D., Mosier D.E. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. J. Immunol. 163(2):1999;861-867
25. Pedroza-Martins L., Boscardin W.J., Anisman-Posner D.J., Schols D., Bryson Y.J., Uittenbogaart C.H. Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants. J. Virol. 76(14):2002;6929-6943
26. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283(5403):1999;857-860
27. Schutten M., van Baalen C.A., Guillon C., Huisman R.C., Boers P.H., Sintnicolaas K., Gruters R.A., Osterhaus A.D. Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure. J. Virol. 75(6):2001;2706-2709
28. Shankar P., Sprang H., Lieberman J. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 19(2):1998;111-120
29. Shankar P., Xu Z., Lieberman J. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood. 94(9):1999;3084-3093
30. Soares M.V., Borthwick N.J., Maini M.K., Janossy G., Salmon M., Akbar A.N. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J. Immunol. 161(11):1998;5909-5917
31. Sorg R.V., McLellan A.D., Hock B.D., Fearnley D.B., Hart D.N. Human dendritic cells express functional interleukin-7. Immunobiology. 198(5):1998;514-526
32. Tagaya Y., Bamford R.N., DeFilippis A.P., Waldmann T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 4(4):1996;329-336
33. Van Baalen C.A., Schutten M., Huisman R.C., Boers P.H., Gruters R.A., Osterhaus A.D. Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro. J. Virol. 72(8):1998;6851-6857
34. van Baarle D., Kostense S., van Oers M.H.J., Hamann D., Miedema F. Failing immune control as a result of impaired CD8+ T cell maturation: CD27 might provide a clue. Trends Immunol. 23(12):2002;586-591
35. von Freeden-Jeffry U., Solvason N., Howard M., Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity. 7(1):1997;147-154
36. Walker B.D., Flexner C., Birch-Limberger K., Fisher L., Paradis T.J., Aldovini A., Young R., Moss B., Schooley R.T. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 86(23):1989;9514-9518
37. Welch P.A., Namen A.E., Goodwin R.G., Armitage R., Cooper M.D. Human IL-7: a novel T cell growth factor. J. Immunol. 143(11):1989;3562-3567
38. Wiles M.V., Ruiz P., Imhof B.A. Interleukin-7 expression during mouse thymus development. Eur. J. Immunol. 22(4):1992;1037-1042
39. Yang O.O., Walker B.D. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:1997;273-311
40. Yang O.O., Kalams S.A., Rosenzweig M., Trocha A., Jones N., Koziel M., Walker B.D., Johnson R.P. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70(9):1996;5799-5806
41. Yang O.O., Kalams S.A., Trocha A., Cao H., Luster A., Johnson R.P., Walker B.D. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71(4):1997;3120-3128
42. Yang O.O., Tran A.C., Kalams S.A., Johnson R.P., Roberts M.R., Walker B.D. Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells. Proc. Natl. Acad. Sci. U.S.A. 94(21):1997;11478- 11483
43. Yang O.O., Nguyen P.T., Kalams S.A., Dorfman T., Gottlinger H.G., Stewart S., Chen I.S., Threlkeld S., Walker B.D. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. J. Virol. 76(4):2002;1626-1631